Brief: Numinus Wellness And Optimi Health Submit All-Natural Psilocybin Extract To Health Canada For Pre-Clinical Trial Application
11/05/2021 14:03
May 11 (Reuters) - Numinus Wellness Inc NUMI.V :
* NUMINUS WELLNESS AND OPTIMI HEALTH SUBMIT ALL-NATURAL
PSILOCYBIN
EXTRACT TO HEALTH CANADA FOR PRE-CLINICAL TRIAL APPLICATION
Source text for Eikon: ID:nCNWztGkRa
Further company coverage: NUMI.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Optimi Health
See all newsExplainer: As Trump backs psychedelics research, FDA weighs safety and access standards
Brief: Optimi Health Corp - Trial Initiation Planned For H1 2027, Dosing To Complete By End Of 2027
Brief: Optimi Health Offers 2.4 MLn Common Shares At A Public Offering Price Of US$6.25 Per Share
Brief: Optimi Health Corp Now Sees IPO Of 2.4 Million Common Shares
Trump's psychedelic drug order boosts investor interest with promise of faster reviews